World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: REBEC
Last refreshed on: 29 April 2013
Main ID:  RBR-6gdyvz
Date of registration: 12/12/2012
Primary sponsor: Universidade Católica de Brasília - Brasília, DF, Brazil
Public title: Effects of Resistance Training on Cardiovascular Risk Factors in Middle Aged Women
Scientific title: Effects of Different Models of Undulating Periodization of Resistance Training on Cardiovascular Risk Parameters, Body Composition, Muscle Strength and Lifespam in Premenopausal Women with Metabolic Syndrome
Date of first enrolment: 10/04/2012
Target sample size: 60
Recruitment status: recruiting
URL:  http://www.ensaiosclinicos.gov.br/rg/RBR-6gdyvz/
Study type: 
Study design:  A randomized controlled trial  
Countries of recruitment
Brazil
Contacts
Name: Ramires  Tibana
Address:  Q.S. 07 Lote 01 – Bloco G 71966-700 Taguatinga Brazil
Telephone: +55(61)9616-8340
Email: ramiires@hotmail.com
Affiliation:  Universidade Católica de Brasília
Name: Ramires  Tibana
Address:  Q.S. 07 Lote 01 – Bloco G 71966-700 Taguatinga Brazil
Telephone: +55(61)9616-8340
Email: ramiires@hotmail.com
Affiliation:  Universidade Católica de Brasília
Key inclusion & exclusion criteria
Inclusion criteria: To be pre-menopausal aged between 18-49 years and no regular practice of exercise in the previous 12 months
Exclusion criteria: Use of drugs that could affect cardiovascular response to exercise and presence of any disease that would compromise their health during the study period.

Age minimum: 18Y
Age maximum: 49Y
Gender: F
Health Condition(s) or Problem(s) studied
Women with different genotypes of polymorphism of the Angiotensin Converting Enzyme (ACE)
C14.907.489
Intervention(s)
Clinical randomized controlled trial, double-blind, 3 arms. Women between 18 and 49 years will be voluntarily recruited from the local community. Each volunteer you be submitted to general physical exams, including: medical history, rest and exercise electrocardiogram, blood pressure measure before the beginning of the resistance training program. After completing the clinical exams for inclusion, will be selected 60 pre-menopausal sedentary women. They will be randomly divided into three groups of 20. Group 1 - will perform weekly undulating periodization of resistance training, group will perform daily undulating periodization, and control group. Initially, will be analyzed: 1)Maximal strength evaluations - after two weeks of adaptation to resistance exercises and clinical evaluation maximal strength (1RM) tests will be performed; 2) Resistance training - will be performed with weekly and daily undulating periodization models. En the daily undulating model, training intensity will be increased in each day of the week, for example, day 1 8-10RM (repetitions maximum) day 2 3-6RM and day 3 12-15RM load, while for the weekly undulating the intensity adjustment will occur weekly, week 1 of 8-10RM, week 2 of 3-6RM and week 3 of 12-15RM; 3) Anthropometry; 4)Body composition - body composition analysis of the volunteers, before and after the training period will be done by the Dual-energy X-ray absorptiometry; 5)Blood pressure - the measure of systolic (SBP) and diastolic blood pressure (DBP), in weeks 0, 12 and 24 will be done by the auscultatory method; 6) Cytokines measure - plasma cytokines and resistin, and salivary immunoglobulin A - saliva drawn will be performed to remove cells from the oral mucosa. Then, swabs tips will be separated with scissors and transferred to 1,5 ml to measure immunoglobulin A in saliva. Blood samples (3ml) will be collected from the antecubital vein with vaccumtainer tubes before, immediately after, 24h and 48h after the first resistance
Primary Outcome(s)
Improvement of the metabolic profile measured by blood cytokines, lipidogram, insulin and glucose
Secondary Outcome(s)
Decrease of the cardiovascular risk factors, also measured by blood pressure parameters after six months
Secondary ID(s)
279/2010
Source(s) of Monetary Support
Universidade Católica de Brasília - Brasília, DF, Brazil
Secondary Sponsor(s)
Universidade Católica de Brasília - Brasília, DF, Brazil
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history